Amalgam Rx Receives Strategic Investment From CVS Health Ventures
Amalgam Rx Receives Strategic Investment From CVS Health Ventures Noah Long
Amalgam Rx – a leader in enabling data-driven healthcare decision-making – recently announced the participation of CVS Health Ventures in its Series B investment round. The funding round supports the scaling of Amalgam’s EHR-integrated clinical decision support platform to provide actionable information for health care providers (HCPs) for use at the point of care. And Amalgam’s technology aligns and helps realize shared savings agreements between payers and HCPs.
Along with CVS Health Ventures investment, Aetna (a CVS Health company) is collaborating with Amalgam at select health systems, implementing Amalgam’s EHR-integrated decision support solutions – which were designed to improve outcomes and reduce the cost of care for Aetna members.
KEY QUOTES:
“Our investment in Amalgam reflects our commitment to redefining health care by making care delivery simpler, more personalized and better connected. Amalgam’s point-of-care decision making capabilities can help further enhance a data-driven model of integrated care, supporting both providers and patients.”
- Vijay Patel, Managing Partner and co-founder of CVS Health Ventures, the company’s dedicated corporate venture capital platform
“Digital Health solutions have become numerous in recent years; however, to be adopted at scale, they must leverage patient-specific data, fit into provider workflow, and align across stakeholder incentives. Delivering actionable insights at the click of a button and driving alignment between payers and providers can help benefit patients and improve health outcomes.”
- Ryan Sysko, chief executive officer of Amalgam